Diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (GlaxoSmithKline)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (GlaxoSmithKline)

Drug Alias Name白喉、破伤风类毒素、无细胞百日咳吸附和灭活的脊髓灰质炎病毒疫苗 - 葛兰素史克Infanrix-IPVDTaP-IPV paediatric vaccine (GlaxoSmithKline)DTaP-poliovirus vaccine paediatric (GlaxoSmithKline)Kinrix

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Vaccine type > Combination vaccine +[5]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4]

Global Approved IndicationsPoliomyelitisTetanusDiphtheria +[4]

Approved Indications in ChinaN/A

Original Approved Country/TerritoryUnited States

Original Approved Date2008/06/14

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Plc

Active IndicationsPoliomyelitisTetanusDiphtheria +[4]

Inactive IndicationsN/A

Other Information

ATC CodeJ07CA02